Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.64
+0.24 (1.46%)
At close: Oct 23, 2026, 4:00 PM EDT
16.49
-0.15 (-0.90%)
After-hours: Oct 23, 2026, 4:10 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $88.37 million as of October 23, 2026. It is the 25,952nd most valuable company in the world and the 4,177th biggest in the United States. Its market cap has increased by 277.02% in one year.
Market Cap
88.37M
Enterprise Value
-4.48M
1-Year Change
277.02%
Global Rank
Country Rank
#4,177 United States
Category
ChartMarket Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $88.37M, a decrease of -78.21%. That is a compound annual growth rate of -25.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 88.37M | 204.89% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OnKure Therapeutics | 93.14M |
| Tonix Pharmaceuticals Holding | 93.13M |
| Genelux | 92.76M |
| Equillium | 90.04M |
| PDS Biotechnology | 89.87M |
| Tenaya Therapeutics | 87.49M |
| Rani Therapeutics Holdings | 84.33M |
| Corbus Pharmaceuticals Holdings | 82.88M |